Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14804
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Boonyaleephan S. | |
dc.date.accessioned | 2021-04-05T04:31:56Z | - |
dc.date.available | 2021-04-05T04:31:56Z | - |
dc.date.issued | 2008 | |
dc.identifier.issn | 1252208 | |
dc.identifier.other | 2-s2.0-58949090429 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/14804 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-58949090429&partnerID=40&md5=2fd3b1ec03ed2ea01f81dd35fadb3257 | |
dc.description.abstract | Objective: Describe bilateral acute onset myopia and angle-closure glaucoma as ocular adverse effects of topiramate. Case Report: A 23 year-old woman developed bilateral severe blurred vision seven days after initiating therapy with topiramate. Her visual acuity was counting fingers in both eyes. Intraocular pressures were 33 mmHg and 32 mmHg in the right and left eyes, respectively, with conjunctival chemosis, corneal edema, shallow anterior chambers, and closed angles. Her refraction was -7.50 diopters in both eyes. The symptoms and clinical findings resolved completely upon discontinuation of topiramate and administration of antiglaucoma drugs. Conclusion: Topiramate use can result in acute bilateral angle-closure glaucoma and myopia, which are usually reversible upon cessation of the drug. Visual outcome is usually good and the episode resolves within a few weeks. Thus, it is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate. | |
dc.subject | acetazolamide | |
dc.subject | amitriptyline | |
dc.subject | antiglaucoma agent | |
dc.subject | glycerol | |
dc.subject | mefenamic acid | |
dc.subject | prednisolone acetate | |
dc.subject | propranolol derivative | |
dc.subject | timolol maleate | |
dc.subject | topiramate | |
dc.subject | acetazolamide | |
dc.subject | anticonvulsive agent | |
dc.subject | antihypertensive agent | |
dc.subject | cryoprotective agent | |
dc.subject | drug derivative | |
dc.subject | fructose | |
dc.subject | glycerol | |
dc.subject | timolol | |
dc.subject | topiramate | |
dc.subject | adult | |
dc.subject | anterior eye chamber | |
dc.subject | article | |
dc.subject | biomicroscopy | |
dc.subject | blurred vision | |
dc.subject | case report | |
dc.subject | chemosis | |
dc.subject | closed angle glaucoma | |
dc.subject | cornea edema | |
dc.subject | drug withdrawal | |
dc.subject | eye examination | |
dc.subject | eye pain | |
dc.subject | eye refraction | |
dc.subject | female | |
dc.subject | human | |
dc.subject | intraocular pressure | |
dc.subject | migraine | |
dc.subject | myopia | |
dc.subject | photography | |
dc.subject | side effect | |
dc.subject | visual acuity | |
dc.subject | acute disease | |
dc.subject | chemically induced disorder | |
dc.subject | closed angle glaucoma | |
dc.subject | drug effect | |
dc.subject | myopia | |
dc.subject | risk factor | |
dc.subject | Acetazolamide | |
dc.subject | Acute Disease | |
dc.subject | Adult | |
dc.subject | Anticonvulsants | |
dc.subject | Antihypertensive Agents | |
dc.subject | Cryoprotective Agents | |
dc.subject | Female | |
dc.subject | Fructose | |
dc.subject | Glaucoma, Angle-Closure | |
dc.subject | Glycerol | |
dc.subject | Humans | |
dc.subject | Intraocular Pressure | |
dc.subject | Myopia | |
dc.subject | Risk Factors | |
dc.subject | Timolol | |
dc.title | Bilateral acute onset myopia and angle closure glaucoma after oral topiramate: A case report | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Journal of the Medical Association of Thailand. Vol 91, No.12 (2008), p.1904-1908 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.